Capstone Investment Advisors
CKPT

Capstone Investment Advisors’s Checkpoint Therapeutics CKPT Stock Holding History

Capstone Investment Advisors’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,764
Closed -$58K – 1872
2021
Q3 		$58K Buy
+1,764
New +$52.1K ﹤0.01% 1835

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capstone Investment Advisors's CKPT Position: Q4 2021 in Review

Capstone Investment Advisors sold out of Checkpoint Therapeutics (CKPT) in Q4 2021, closing a stake of 1,764 shares — an estimated $58K sold.

Capstone Investment Advisors first reported a position in CKPT in Q3 2021 and held it in 1 quarter. The position peaked at $58K in Q3 2021. 62 funds tracked by Wall St. Rank hold CKPT as of Q4 2021.

  • Capstone Investment Advisors reported no remaining Checkpoint Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Capstone Investment Advisors sold 1,764 Checkpoint Therapeutics shares in Q4 2021, an estimated $58K.
  • Capstone Investment Advisors first reported a position in Checkpoint Therapeutics in Q3 2021 and held it in 1 quarter.
  • Capstone Investment Advisors's Checkpoint Therapeutics position peaked at $58K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q4 2021.

Based on Capstone Investment Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.